Clinical Trial Update: A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH. [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, and pharmacokinetics of AZD7503 in participants with suspected nonalcoholic steatohepatitis has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• AZD7503

Snippet

Sponsor: AstraZeneca | Conditions: Steatohepatitis | Phase 1 | Status: TERMINATED